BioHarvest to Expand Production Capacity Fourfold by 2026
BioHarvest plans to expand its production capacity by four times by building a new 100 ton per year production facility, expected to be operational in late 2026. This expansion reflects the company’s confidence in its business trajectory.
"We spent 15 years and over $100M to develop the Botanical Synthesis Process Technology," said BioHarvest CEO Ilan Sobel. "The VINIA red grape cell molecule was the first composition developed on our platform and is now a powerful validation that our Botanical Synthesis technology can create highly efficacious, patentable, plant-based molecules at scale."
Sobel added, "In addition to the compounds within our Products division pipeline, our growing CDMO Services division now has multiple compounds being developed under contract with Pharmaceutical and Nutrition industry partners. I am confident that we have the plan and the team in place to achieve our vision of developing life-changing compounds from plants that improve the health and wellness of millions of people, whilst preserving the planet for generations to come."
